Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Invest NowAditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Invest NowChart Comparison
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8689 Cr | ₹882 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.81 | 2.28 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | -3.66% | -3.56% |
6 Month | 7.39% | 6.36% |
1 Year | 21.43% | 21.63% |
3 Year | 19.27% | 17.7% |
5 Year | 25.83% | 22.13% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | - | - |
1 Year | 14.69% | 12.96% |
3 Year | 27.2% | 26.62% |
5 Year | 22.9% | 21.06% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 17.79% | 28.8% |
3 Year | 20.87% | 15.16% |
5 Year | 20.18% | 25.28% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 14.36% | 14.83% |
Sharp | 0.78% | 0.61% |
Beta | 0.87% | 0.96% |
Alpha | 1.67% | 0.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Fund Manage | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 4.4 | 7.99 |
Large Cap | 45.96 | 41.75 |
Mid Cap | 27.12 | 31.34 |
Small Cap | 22.52 | 18.91 |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 4.4 | 7.99 |
Pharmaceuticals & Biotechnology | 75.86 | 71.97 |
Healthcare Services | 17.38 | 15.51 |
Retailing | 2.36 | - |
Chemicals & Petrochemicals | - | 0.91 |
Insurance | - | 3.61 |
Top Comparisons
Sundaram Equity Savings Fund (G)
3Y Returns9.69%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns11.55%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns17.22%
Canara Robeco Focused Equity Fund - Regular Plan - Growth Option
3Y Returns13.38%
Sundaram Short Duration Fund Regular Growth
3Y Returns6.15%
SBI Short Horizon Debt Fund-Short Term Fund - Retail - Growth
3Y Returns6.04%
Mahindra Manulife ELSS Tax Saver Fund- Regular Plan - Growth
3Y Returns10.97%
Quant ELSS Tax Saver Fund Regular Plan-Growth
3Y Returns14.75%